DAX24.198 +1,0%ESt505.379 +0,8%Top 10 Crypto16,26 +0,2%Dow44.838 -0,1%Nas21.179 +0,3%Bitcoin102.737 +1,1%Euro1,1567 -0,2%Öl70,42 ±0,0%Gold3.327 +0,4%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Volkswagen (VW) vz. 766403 RENK RENK73 Mercedes-Benz Group (ex Daimler) 710000 Lufthansa 823212 Bayer BAY001 Deutsche Bank 514000 Tesla A1CX3T BASF BASF11 DroneShield A2DMAA Porsche PAG911 Novo Nordisk A3EU6F HENSOLDT HAG000 Deutsche Telekom 555750
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Erholungsversuch: DAX legt zu -- Asiens Börsen schließen uneins -- Uniper erwartet Ergebniseinbruch -- Heidelberger Druckmaschienen, SUSS, TeamViewer, Hypoport, Tilray im Fokus
Top News
Ist passives Investieren mit ETFs wirklich "Investieren für Faule"? Ist passives Investieren mit ETFs wirklich "Investieren für Faule"?
Redcare Pharmacy-Aktie profitiert: Sondereffekt verhilft Redcare Pharmacy zu Nettogewinn Redcare Pharmacy-Aktie profitiert: Sondereffekt verhilft Redcare Pharmacy zu Nettogewinn
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Ãœbersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Deutscher Zertifikatepreis 2025: Jetzt abstimmen und attraktive Preise gewinnen!

Sage Therapeutics Aktie

Handeln
Aktien-Sparplan anlegen
7,49 EUR -0,06 EUR -0,79 %
FSE
8,81 USD +0,03 USD +0,28 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.475,84 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA117WF

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS78667J1088

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolSAGE

Sage Therapeutics Aktien News

DatumMeistgelesen
PR NewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, SAGE, SOL on Behalf of Shareholders
PR NewswireALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.
PR NewswireSAGE THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc. - SAGE
Wer­bungSage Therapeutics-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireSage Potash Closes C$2.5 Million Private Placement
PR NewswireSage Potash Closes C$2.5 Million Private Placement
PR NewswireSage Potash Provides Updates to Equipment Purchase and Financing
PR NewswireSage Potash Closes Private Placement
PR NewswireSage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE
PR NewswireSage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE
PR NewswireSage Potash Continues to Strengthen Team by Adding Corporate Finance Veteran as CFO and Retains Terrarock Industries for Plant Construction
PR NewswireSage Potash Continues to Strengthen Team by Adding Corporate Finance Veteran as CFO and Retains Terrarock Industries for Plant Construction
PR NewswireSage Potash Continues to Strengthen Team by Adding Corporate Finance Veteran as CFO and Retains Terrarock Industries for Plant Construction
PR NewswireShareholders of Sage Therapeutics, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - SAGE
PR NewswireShareholders that lost money on Sage Therapeutics, Inc.(SAGE) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
PR NewswireSage Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - SAGE
PR NewswireSAGE INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $00,000 In XXX To Contact Him Directly To Discuss Their Options
PR NewswireSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit
PR NewswireThe Gross Law Firm Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SAGE
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE
PR NewswireSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit
PR NewswireSage Potash Shares to Resume Trading
PR NewswireSage Potash Shares to Resume Trading
PR NewswireCanadian Investment Regulatory Organization Trade Resumption - SAGE
PR NewswireCanadian Investment Regulatory Organization Trade Resumption - SAGE
PR NewswireSAGE SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE
PR NewswireCanadian Investment Regulatory Organization Trading Halt - SAGE
PR NewswireCanadian Investment Regulatory Organization Trading Halt - SAGE
PR NewswireSage Potash Announces Equipment Purchase and Financing
PR NewswireSage Potash Announces Equipment Purchase and Financing
PR NewswireSage Potash Announces Equipment Purchase and Financing
PR NewswireSage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE
PR NewswireSAGE SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE
PR NewswireSAGE POTASH ANNOUNCES APPOINTMENTS OF A NEW BOARD OF DIRECTORS MEMBER, STRATEGIC OPERATIONS PARTNER AND GLOBAL FINANCE & TRADE PARTNER

Sage Therapeutics News

Sage Therapeutics News: auf dieser Seite finden Sie alle Sage Therapeutics News und Nachrichten zur Sage Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sage Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sage Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.